Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons

Marina Guizzetti, Nadia H. Moore, Kathryn L. VanDeMark, Gennaro Giordano, Lucio G. Costa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Astrocytes have been shown to release factors that affect various aspects of neuronal development. We have previously shown that the acetylcholine analog carbachol, by activating muscarinic M3 receptors in rat astrocytes, increases their ability to promote neuritogenesis in hippocampal neurons. This effect was mediated by an increased expression and release by astrocytes of several permissive factors, a most relevant of which was fibronectin. In the present study we investigated the signal transduction pathways involved in these effects of carbachol in astrocytes. Results show that multiple pathways are involved in the effects of carbachol on astrocyte-mediated increases in fibronectin expression and neuritogenesis. These include the phospholipase D pathway, leading to sequential activation of protein kinase C (PKC) ζ, p70S6 kinase and nuclear factor-κB; the phosphoinositide-3 kinase pathway; and the PKC ε pathway leading to activation of mitogen activated protein kinase. These pathways were shown to mediate the effect of carbachol on neurite outgrowth as well as the increased expression of fibronectin, further substantiating the important role of the latter in astrocyte-mediated neuritogenesis. Interference with these signaling pathways would be expected to impair astrocyte-neurons communication leading to impaired neuronal development.

Original languageEnglish (US)
Pages (from-to)102-107
Number of pages6
JournalEuropean Journal of Pharmacology
Volume659
Issue number2-3
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Muscarinic Receptors
Astrocytes
Signal Transduction
Neurons
Carbachol
Fibronectins
Muscarinic M3 Receptors
Phospholipase D
Aptitude
1-Phosphatidylinositol 4-Kinase
Mitogen-Activated Protein Kinases
Protein Kinase C
Acetylcholine
Communication

Keywords

  • Astrocyte
  • Fibronectin
  • Hippocampal neuron
  • Muscarinic receptor
  • Neuritogenesis
  • Signal transduction

ASJC Scopus subject areas

  • Pharmacology

Cite this

Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons. / Guizzetti, Marina; Moore, Nadia H.; VanDeMark, Kathryn L.; Giordano, Gennaro; Costa, Lucio G.

In: European Journal of Pharmacology, Vol. 659, No. 2-3, 01.06.2011, p. 102-107.

Research output: Contribution to journalArticle

Guizzetti, Marina ; Moore, Nadia H. ; VanDeMark, Kathryn L. ; Giordano, Gennaro ; Costa, Lucio G. / Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons. In: European Journal of Pharmacology. 2011 ; Vol. 659, No. 2-3. pp. 102-107.
@article{b1f8be8637824f2eb3862de07b6d0625,
title = "Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons",
abstract = "Astrocytes have been shown to release factors that affect various aspects of neuronal development. We have previously shown that the acetylcholine analog carbachol, by activating muscarinic M3 receptors in rat astrocytes, increases their ability to promote neuritogenesis in hippocampal neurons. This effect was mediated by an increased expression and release by astrocytes of several permissive factors, a most relevant of which was fibronectin. In the present study we investigated the signal transduction pathways involved in these effects of carbachol in astrocytes. Results show that multiple pathways are involved in the effects of carbachol on astrocyte-mediated increases in fibronectin expression and neuritogenesis. These include the phospholipase D pathway, leading to sequential activation of protein kinase C (PKC) ζ, p70S6 kinase and nuclear factor-κB; the phosphoinositide-3 kinase pathway; and the PKC ε pathway leading to activation of mitogen activated protein kinase. These pathways were shown to mediate the effect of carbachol on neurite outgrowth as well as the increased expression of fibronectin, further substantiating the important role of the latter in astrocyte-mediated neuritogenesis. Interference with these signaling pathways would be expected to impair astrocyte-neurons communication leading to impaired neuronal development.",
keywords = "Astrocyte, Fibronectin, Hippocampal neuron, Muscarinic receptor, Neuritogenesis, Signal transduction",
author = "Marina Guizzetti and Moore, {Nadia H.} and VanDeMark, {Kathryn L.} and Gennaro Giordano and Costa, {Lucio G.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.ejphar.2011.03.019",
language = "English (US)",
volume = "659",
pages = "102--107",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons

AU - Guizzetti, Marina

AU - Moore, Nadia H.

AU - VanDeMark, Kathryn L.

AU - Giordano, Gennaro

AU - Costa, Lucio G.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Astrocytes have been shown to release factors that affect various aspects of neuronal development. We have previously shown that the acetylcholine analog carbachol, by activating muscarinic M3 receptors in rat astrocytes, increases their ability to promote neuritogenesis in hippocampal neurons. This effect was mediated by an increased expression and release by astrocytes of several permissive factors, a most relevant of which was fibronectin. In the present study we investigated the signal transduction pathways involved in these effects of carbachol in astrocytes. Results show that multiple pathways are involved in the effects of carbachol on astrocyte-mediated increases in fibronectin expression and neuritogenesis. These include the phospholipase D pathway, leading to sequential activation of protein kinase C (PKC) ζ, p70S6 kinase and nuclear factor-κB; the phosphoinositide-3 kinase pathway; and the PKC ε pathway leading to activation of mitogen activated protein kinase. These pathways were shown to mediate the effect of carbachol on neurite outgrowth as well as the increased expression of fibronectin, further substantiating the important role of the latter in astrocyte-mediated neuritogenesis. Interference with these signaling pathways would be expected to impair astrocyte-neurons communication leading to impaired neuronal development.

AB - Astrocytes have been shown to release factors that affect various aspects of neuronal development. We have previously shown that the acetylcholine analog carbachol, by activating muscarinic M3 receptors in rat astrocytes, increases their ability to promote neuritogenesis in hippocampal neurons. This effect was mediated by an increased expression and release by astrocytes of several permissive factors, a most relevant of which was fibronectin. In the present study we investigated the signal transduction pathways involved in these effects of carbachol in astrocytes. Results show that multiple pathways are involved in the effects of carbachol on astrocyte-mediated increases in fibronectin expression and neuritogenesis. These include the phospholipase D pathway, leading to sequential activation of protein kinase C (PKC) ζ, p70S6 kinase and nuclear factor-κB; the phosphoinositide-3 kinase pathway; and the PKC ε pathway leading to activation of mitogen activated protein kinase. These pathways were shown to mediate the effect of carbachol on neurite outgrowth as well as the increased expression of fibronectin, further substantiating the important role of the latter in astrocyte-mediated neuritogenesis. Interference with these signaling pathways would be expected to impair astrocyte-neurons communication leading to impaired neuronal development.

KW - Astrocyte

KW - Fibronectin

KW - Hippocampal neuron

KW - Muscarinic receptor

KW - Neuritogenesis

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=79955938415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955938415&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2011.03.019

DO - 10.1016/j.ejphar.2011.03.019

M3 - Article

VL - 659

SP - 102

EP - 107

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -